Seems fitting that our editorial "Diffuse midline glioma, H3K27-altered: Illuminating the dark side of the moon" discussing DMG's lack of treatment vs the pioneering discoveries of Sidney Faber is published while @PNOC_kids meeting @DanaFarber in Boston
https://t.co/GyqltUzGVt
Thank you @RobertReya for the fantastic and considered commentary on our recent @jclinicalinvest publication on PI3K/PKC in DIPG/DMG.
https://t.co/JjuJkgedbS
Today on International Childhood Cancer Day, join us in raising awareness for this disease that takes away too many childhoods.
We will keep working until there is a cure.
Share this post to amplify this message. ๐งก ๐
#ICCD#ChildhoodCancer#DefeatDIPG
It's been a dream to bring better treatments to kids with #DIPG & #CNStumors. It's thrilling to announce #BrainChildBio a kids first biotech advancing #CARTcells for CNS tumors (CEO Steve Brugger; CSO Mike Jensen, MD) in partnership with @seattlechildren.
https://t.co/6KGGE22gbL
3rd Annual #rallyforraegan Toy Drive benefiting @JDCHospital. Link attached for Amazon Wish list: https://t.co/RWzuePMnYm
Thank you everyone for your generosity and kindness! ๐๐๐ป๐
Join us in congratulating Dr. Javad Nazarian on his new role as Co-Chair of the #CBTN Scientific Committee. His passion for pediatric brain tumor research is driving progress.
Discover his inspiring story: https://t.co/4RLAu2boNn
#wearecbtn
A new study, written by Dr. Carl Koschmann and his team at Michigan Medicine, has been published in Acta Neuropathologica, representing a significant breakthrough in the field of brain cancer research.
Read the study here: https://t.co/WgbYnHhQNq
@CarlKoschmann@KoschmannLab
After experiencing headaches, Peyton came to the Children's Emergency Department and was diagnosed with mixed phenotype leukemia. She spent the next few years at the Aflac Cancer and Blood Disorders Center for treatments. Next week, Peyton is returning to Children'sโas a nurse.
Diffuse midline glioma #DMG is uniformly fatal & the leading killer of kids
Currently it lacks approved treatments other than radiotherapy
Dordaviprone #ONC201 shows a prelim benefit for #DIPG patients, by why?
Here we summarise it's mechanisms to show why
https://t.co/tz5pIvHba4
A new manuscript published today reports ONC201 nearly doubles survival rates for patients with DIPG/DMG.
Carl Koschmann, M.D. and Sriram Venneti, M.D., Ph.D., of @umichmedicine sat down to discuss these exciting findings.
Read the full paper here: https://t.co/9FCd75kzhR
#Rallyforraegan ๐ฆ New design! Multiple colors and styles, available for presale all month, ALL proceeds go to help #DIPG pts and families ๐ #pediatriccancer#dmg
https://t.co/lnCzneHqfH
$17,638 Raised!! Because of YOU!! ๐ Thank you so much to everyone that came out today for the 3rd Annual Rally For Raegan 5k Run/Walk!
DIPG You will be defeated!
See everyone again next year! ๐๐ค๐ป
#rallyforraegan@chadtough@ATLPedsHemOnc@DefeatDIPG